Literature DB >> 4025116

Left ventricular performance in septic shock: reversible segmental and global abnormalities.

A G Ellrodt, M S Riedinger, A Kimchi, D S Berman, J Maddahi, H J Swan, G H Murata.   

Abstract

Left ventricular dysfunction has been implicated in the pathogenesis of septic shock, but little is known about its natural history, cause, and prognostic significance. Left ventricular performance was assessed by serial radionuclide and hemodynamic studies in 35 patients with culture-proven septic shock. The mean age (+/- S.D.) of the group was 64 +/- 18 years; 16 of the subjects were women, and 15 had antecedent heart disease. On the first study, the left ventricular stroke work index was depressed in 33 (94%) patients, and nineteen (54%) had a left ventricular ejection fraction less than 0.48. Twenty-two (63%) of the patients had segmental and four had generalized wall motion abnormalities. Conventional hemodynamic parameters were of no value in predicting the patients who had a depressed left ventricular ejection fraction or segmental abnormalities. Patients with underlying heart disease had a much higher frequency (87%) of segmental dysfunction than those without underlying heart disease (45%; p = 0.016), but no differences were noted in the left ventricular ejection fraction or left ventricular stroke work index of these two groups. Segmental abnormalities and low ejection fractions were seen more often in patients with a large left ventricular end-diastolic volume index. Only five subjects had a systemic vascular resistance index greater than 2580 dynes X sec X cm-5 per m2, and the correlation between systemic vascular resistance index and left ventricular ejection fraction was poor. No difference was found in the mean coronary perfusion pressure of those with segmental abnormalities and those with normal wall motion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4025116     DOI: 10.1016/0002-8703(85)90163-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  36 in total

1.  Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression?

Authors:  A H Wu
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

2.  Peripheral vascular resistance in septic shock: its relation to outcome.

Authors:  A B Groeneveld; J J Nauta; L G Thijs
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

3.  Septic shock: a heart story since the 1960s.

Authors:  C Rabuel; A Mebazaa
Journal:  Intensive Care Med       Date:  2006-03-29       Impact factor: 17.440

4.  Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.

Authors:  F D Pagani; L S Baker; C Hsi; M Knox; M P Fink; M S Visner
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 5.  The haemodynamics of septic shock.

Authors:  L G Thijs; A J Schneider; A B Groeneveld
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 6.  Sepsis, apoptosis and complement.

Authors:  P A Ward
Journal:  Biochem Pharmacol       Date:  2008-09-20       Impact factor: 5.858

Review 7.  Cardiac dysfunction in sepsis: new theories and clinical implications.

Authors:  R M Grocott-Mason; A M Shah
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

8.  The effects of lazaroid U-74389G in a rat sepsis model.

Authors:  Yun-Te Chang; Shue-Ren Wann; Kai-Hseng Hsieh; Yung-Ching Liu; Ching-Hsiung Chang; Mu-Shun Huang; Chun-I Huang; Hong-Tai Chang
Journal:  Inflamm Res       Date:  2010-07-11       Impact factor: 4.575

Review 9.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

10.  Invasive monitoring combined with two-dimensional echocardiographic study in septic shock.

Authors:  F Jardin; B Valtier; A Beauchet; O Dubourg; J P Bourdarias
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.